IRIS
SALTINI, CESARE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.432
EU - Europa 2.703
AS - Asia 2.606
SA - Sud America 358
AF - Africa 39
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 27.162
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.372
SG - Singapore 1.183
DE - Germania 688
CN - Cina 648
UA - Ucraina 401
IT - Italia 336
BR - Brasile 305
RU - Federazione Russa 285
IE - Irlanda 216
VN - Vietnam 212
FR - Francia 211
HK - Hong Kong 193
GB - Regno Unito 167
SE - Svezia 150
FI - Finlandia 126
KR - Corea 92
IN - India 66
JP - Giappone 66
CA - Canada 32
PL - Polonia 23
AR - Argentina 22
MX - Messico 22
ID - Indonesia 16
BD - Bangladesh 15
ES - Italia 15
RO - Romania 15
BE - Belgio 14
NL - Olanda 14
AU - Australia 13
IL - Israele 13
TR - Turchia 13
AT - Austria 12
ZA - Sudafrica 12
IQ - Iraq 11
TW - Taiwan 10
TH - Thailandia 9
UZ - Uzbekistan 9
EC - Ecuador 8
CL - Cile 7
EU - Europa 7
MY - Malesia 7
KG - Kirghizistan 6
LY - Libia 6
PE - Perù 6
PK - Pakistan 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
NG - Nigeria 5
BG - Bulgaria 4
IR - Iran 4
PH - Filippine 4
VE - Venezuela 4
CH - Svizzera 3
CO - Colombia 3
JO - Giordania 3
MA - Marocco 3
AO - Angola 2
BH - Bahrain 2
DK - Danimarca 2
EE - Estonia 2
HU - Ungheria 2
LB - Libano 2
LT - Lituania 2
MD - Moldavia 2
NO - Norvegia 2
RS - Serbia 2
SI - Slovenia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
GA - Gabon 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NP - Nepal 1
NR - Nauru 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
PY - Paraguay 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 27.162
Salva come PNG Salva come JPEG
Città #
Woodbridge 6.450
Wilmington 5.034
Houston 4.490
Ann Arbor 717
Singapore 652
Fairfield 569
Jacksonville 392
Ashburn 385
Chandler 323
San Jose 269
Beijing 267
Seattle 231
Dublin 214
Cambridge 211
Hong Kong 188
Medford 168
Dearborn 164
New York 106
The Dalles 105
Rome 95
Santa Clara 92
Lawrence 82
Ho Chi Minh City 66
Los Angeles 65
Zhengzhou 62
Dallas 56
Hanoi 54
Tokyo 53
Menlo Park 50
Council Bluffs 49
Mülheim 47
Hangzhou 43
Helsinki 42
Lauterbourg 39
San Diego 38
Buffalo 36
Milan 28
São Paulo 26
Boardman 24
Guangzhou 23
Chicago 22
Moscow 22
Shanghai 20
San Mateo 19
Redwood City 18
Verona 18
Falls Church 17
Redondo Beach 17
University Park 17
Nanjing 16
Norwalk 16
Columbus 14
Orem 14
Brussels 13
London 13
Nuremberg 13
Rio de Janeiro 13
Denver 12
Kraków 12
Palo Alto 12
Toronto 11
Atlanta 10
Chennai 10
Jakarta 10
Mountain View 10
Baghdad 9
Detroit 9
Haiphong 9
Montreal 9
New Delhi 9
Da Nang 8
Hefei 8
Johannesburg 8
Kunming 8
Poplar 8
Stockholm 8
Warsaw 8
Auburn Hills 7
Hải Dương 7
Liverpool 7
Manchester 7
Mcallen 7
Vienna 7
Washington 7
Belo Horizonte 6
Dong Ket 6
Frankfurt am Main 6
Fremont 6
Joinville 6
Mumbai 6
Munich 6
San Francisco 6
Seoul 6
Tashkent 6
Biberach an der Riss 5
Boston 5
Brooklyn 5
Delhi 5
Mexico City 5
Philadelphia 5
Totale 22.614
Salva come PNG Salva come JPEG
Nome #
Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy 788
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study 554
Awake thoracoscopic biopsy of interstitial lung disease 522
Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection 505
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD 501
Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection 492
A model of phenotypic susceptibility to tuberculosis: Deficient in silico selection of Mycobacterium tuberculosis epitopes by HLA alleles 471
Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. 464
M. avium binding to HLA-DR expressed alleles in silico: A model of phenotypic susceptibility to sarcoidosis 458
HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis 458
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity 452
Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69 447
Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis 446
Lysophosphatidic acid enhances antimycobacterial activity both in vitro and ex vivo 443
Metodo per la diagnosi in vitro di fibrosi polmonare/polmonite interstiziale idiopatica e uso di chelanti del ferro per il trattamento della fibrosi polmonare/polmonite interstiziale idiopatica 443
Metabolic syndrome and risk of pulmonary involvement 442
Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity 435
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema 434
Transcriptional profile of the immune response in the lungs of patients with active tuberculosis 433
Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity 431
Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom 428
Evaluation of a western blot test as a potential screening tool for occupational exposure to Mycobacterium tuberculosis in health care workers 421
Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis? 420
Iron laden macrophages in idiopathic pulmonary fibrosis: The telltale of occult alveolar hemorrhage? 420
A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD 418
Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test 418
Biomarkers of lung damage associated with tobacco smoke in induced sputum 417
Immunogenetic basis of environmental lung disease: Lessons from the berylliosis model 413
Beryllium disease 410
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers 400
Uso di peptidi marcatori di sopravvivenza di Mycobacterium tuberculosis per la diagnosi e la prevenzione di infezione tubercolare e relativo kit diagnostico. 400
Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells 398
HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells 398
Peptidi antigenici per uso diagnostico e di vaccinazione anti-tubercolare 389
Neuroendocrine changes involved in the genesis of HD-induced orthostatic intolerance 388
Antibody repertoire against the A60 antigen complex during the course of pulmonary tuberculosis 383
Sensitivity and specificity of a multi-antigen ELISA test for the serological diagnosis of tuberculosis 382
Synthetic peptides for use in the diagnosis and therapy of chronic granulomatous beryllium disease 381
[Mycobacterium tuberculosis. From the gene to the diagnosis] 379
Uso di sequenze amminoacidiche da Mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino 377
Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69 374
Early abnormalities of the antibody response against Mycobacterium tuberculosis in human immunodeficiency virus infection 372
Evaluation of a multi-antigen test based on B-cell epitope peptides for the serodiagnosis of pulmonary tuberculosis 371
Major histocompatibility locus genetic markers of beryllium sensitization and disease 367
Serum CA 15-3 is increased in pulmonary fibrosis. 365
Serological markers predicting tuberculosis in human immunodeficiency virus-infected patients 361
Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin 359
Predicting survival in newly diagnosed idiopatic pulmonary fibrosis : a 3 years prospective study 356
Method for in vitro diagnosis of idiopathic pulmonary fibrosis 348
New perspectives in the treatment of idiopathic pulmonary fibrosis 347
Head-down bed rest reduces the breathing rate short-term variability in subjects with orthostatic intolerance 345
Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells 344
Evaluation of a western blot serum test for the diagnosis of Mycobacterium tuberculosis infection 339
Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease 320
QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens. 318
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. 241
Chemotherapy and diagnosis of tuberculosis 234
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease 221
An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease 205
Novel approaches to the treatment of bacterial lower respiratory tract infections: Introduction 183
Autonomic nervous system dysfunction in the course of active pulmonary tuberculosis 181
Molecular diagnosis of fatal Nocardia farcinica pneumonia in an HIV-negative patient 177
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial 176
Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis 168
Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: A meta-analysis 166
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. 166
Difficult diagnosis of infliximab-related miliary tuberculosis 161
Cost determinants of tuberculosis management in a low-prevalence country 157
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial. 150
Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: Meta-analysis and metaregression 146
HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease 143
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000 137
Markers of anti-oxidant response in tobacco smoke exposed subjects: a data-mining review. 135
Immunogenetics of severe respiratory infections: Models for the development of new therapeutic strategies 133
Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good. 132
Mycobacterium tuberculosis complex drug resistance in Italy 120
Predictive valdue of BAL cellular analysis in differentiating pulmonary tuberculosis and sarcoidosis (multiple letters) [3] 116
Massive haemoptysis from an aberrant bronchial artery in a patient with cavitary pulmonary tuberculosis 116
Interstitial lung disease induced by exogenous agents: factors governing susceptibility 114
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. 111
Schedule or dosage? The need to perfect intermittent regimens for tuberculosis 107
In pursuit of tuberculosis in the pleural space: What more is required? [3] (multiple letters) 104
Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation 67
Totale 27.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.430
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021237 0 0 0 0 0 0 0 0 0 0 180 57
2021/2022808 17 81 57 70 21 95 39 31 54 85 53 205
2022/2023942 97 62 14 148 83 234 82 42 78 6 74 22
2023/2024357 55 15 43 7 22 99 17 17 21 13 10 38
2024/20251.738 90 419 204 103 47 68 163 119 190 150 115 70
2025/20262.626 218 179 350 260 268 104 330 307 369 236 5 0
Totale 27.212